Spots Global Cancer Trial Database for Microwave Ablation in Chinese Patients With Lung Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Microwave Ablation in Chinese Patients With Lung Tumors
Official Title: A Single-Arm, Prospective, Multicenter Study to Evaluate the Effectiveness and Safety of the NeuWave Certus Microwave Ablation System in Chinese Patients With Primary or Secondary Tumors in the Lung
Study ID: NCT04889989
Conditions
Interventions
Study Description
Brief Summary: Adult patients with non-small cell lung cancer (NSCLC) or oligometastatic lung tumors will all receive microwave ablation (MWA) performed percutaneously by doctors who are experienced in lung tumor ablation. 120 patients will participate across 8 clinical study sites all in China.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Hospital, Beijing, , China
Pecking University Shenzhen Hospital, Beijing, , China
The First Affiliated Hospital of Fujian Medical University, Fujian, , China
The Fourth Affiliated Hospital of Harbin Medical University, Harbin, , China
Henan Cancer Hospital, Henan, , China
Hunan Cancer Hospital, Hunan, , China
Qilu Hospital of Shandong University, Shandong, , China
Fudan University Shanghai Cancer Hospital, Shanghai, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
